Skip to main content
This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Topics related to the neuroendocrine-immune axis are given special emphasis in view of the growing interest in stress-related, inflammatory, autoimmune, and degenerative disorders.

Publisher: Bentham Science Publishers

More about this publication?
Volume 10, Number 1, 2010

Articles

Imatinib Mesylate (GleevecĀ©): Targeted Therapy Against Cancer with Immune Properties
pp. 1-7(7)
Authors: Zoubir, Moustapha; Tursz, Thomas; Menard, Cedric; Zitvogel, Laurence; Chaput, Nathalie

Favourites:
ADD

Cross-talk Between Exogenous Statins and Endogenous High-Density Lipoprotein in Anti-Inflammatory and Anti-Atherogenic Actions
pp. 8-15(8)
Authors: Kimura, Takao; Sato, Koichi; Tomura, Hideaki; Okajima, Fumikazu

Favourites:
ADD
Favourites:
ADD

Metabolic Syndrome Components in Murine Models
pp. 25-40(16)
Authors: Lawson, Heather A.; Cheverud, James M.

Favourites:
ADD

Antitumor Activities of Interleukin-27 on Melanoma
pp. 41-46(6)
Authors: Nagai, Hiroshi; Oniki, Shuntaro; Fujiwara, Susumu; Xu, Mingli; Mizoguchi, Izuru; Yoshimoto, Takayuki; Nishigori, Chikako

Favourites:
ADD
Favourites:
ADD

Does It Make Sense that Diabetes is Reciprocally Associated with Periodontal Disease?
pp. 57-70(14)
Authors: Santacroce, Luigi; Carlaio, Roberto G.; Bottalico, Lucrezia

Favourites:
ADD

The Central Role of Macrophages in Trypanosomiasis-Associated Anemia:Rationale for Therapeutical Approaches
pp. 71-82(12)
Authors: Stijlemans, Benoit; Vankrunkelsven, Ann; Caljon, Guy; Bockstal, Viki; Guilliams, Martin; Bosschaerts, Tom; Beschin, Alain; Raes, Geert; Magez, Stefan; Baetselier, Patrick D.

Favourites:
ADD

Free Content Erratum
pp. 83-83(1)
Author: Bentham Science Publishers

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content